| SILVER SULFADIAZINE (sul-fa-dye'a-zeen)
 Silvadene
 Classifications: sulfonamide;  Therapeutic: topical antiinfective
 Prototype: Sulfisoxazole
 Pregnancy Category: B
 
 | 
 
 
 
 Availability
 
 1%/50 g cream
 
 Action
 
 Silver salt is released slowly and exerts bactericidal effect only on bacterial cell membrane and wall, rather than by inhibiting 
 folic acid synthesis; antibacterial activity is not inhibited by p-aminobenzoic acid (PABA). 
 
 
 Therapeutic Effect
 
 Broad antimicrobial activity including many gram-negative and gram-positive bacteria and yeast.
 
 Uses
 
 Prevention and treatment of sepsis in second- and third-degree burns.
 
 Contraindications
 
 Hypersensitivity to other sulfonamides; pregnant women at term, premature infants and neonates <1 mo.
 
 Cautious Use
 
 Impaired kidney or liver function; porphyria; impaired respiratory function; G6PD deficiency; thrombocytopenia, leukopenia, 
 hematological disease; pregnancy (category B), lactation. 
 
 
 Route & Dosage
 
  
  
 | Burn Wound Treatment Adult/Child: Topical Apply 1% cream 12 times/d to thickness of approximately 1.5 mm (1/16 in.)
 
 | 
 
 
 
 
Administration
Topical 
 - Do not use if cream darkens; it is water soluble and white.
- Apply with sterile, gloved hands to cleansed, debrided burned areas. Reapply cream to areas where it has been removed by 
 patient activity; cover burn wounds with medication at all times. 
 
- Bathe patient daily (in whirlpool or shower or in bed) as aid to debridement. Reapply drug.
-  	Note: Dressings are not required but may be used if necessary. Drug does not stain clothing. 
- Store at room temperature away from heat.
Adverse Effects (≥1%)
Body as a Whole: Pain (occasionally), burning, itching, rash, reversible leukopenia. Potential for toxicity as for other sulfonamides if 
 applied to extensive areas of the body surface. 
 
Interactions
Drug: proteolytic enzymes are inactivated by silver in cream. 
 
Pharmacokinetics
Absorption: Not absorbed through intact skin, however, approximately 10% could be absorbed when applied to second- or third-degree 
 burns. 
Distribution: Distributed into most body tissues. 
Metabolism: In the liver. 
Elimination: In urine. 
 
Nursing Implications
 
 Assessment & Drug Effects
 
  
 - Observe for and report hypersensitivity reaction: Rash, itching, or burning sensation in unburned areas.
- Lab tests: Obtain serum sulfa concentrations, urinalysis, and kidney function tests when drug is applied to extensive areas. 
 Significant quantities of drug may be absorbed. 
 
- Observe patient for reactions attributed to sulfonamides.
-  	Note: Analgesic may be required. Occasionally, pain is experienced on application; intensity and duration depend on depth of burn. 
- Continue treatment until satisfactory healing or burn site is ready for grafting, unless adverse reactions occur.